Align Technology | ALGN - Selling And Administration Expenses

Stock Price
163.63
Daily Change
0.60 0.37%
Monthly
2.19%
Yearly
-24.18%
Q1 Forecast
158.01

Align Technology reported $417.8M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
3M USD 965M 145M Dec/2025
Align Technology USD 417.8M 30.89M Sep/2025
Becton, Dickinson and Co. USD 1.37B 46M Sep/2025
Bruker USD 242.5M 11.1M Sep/2025
Cardinal Health USD 1.46B 23M Sep/2025
Charles River Laboratories USD 177.59M 8.23M Sep/2025
Cooper Companies USD 419.2M 12M Sep/2025
Danaher USD 2.03B 35M Dec/2025
Dentsply International USD 355M 21M Sep/2025
Dexcom USD 331.4M 3.4M Sep/2025
Henry Schein USD 760M 17M Sep/2025
Idexx Laboratories USD 265.09M 5.3M Sep/2025
Insulet USD 315.2M 61.9M Sep/2025
Integra LifeSciences USD 169.05M 10.84M Sep/2025
IQVIA Holdings USD 514M 5M Sep/2025
Masimo USD 116.4M 20.5M Sep/2025
McKesson USD 2.07B 122M Sep/2025
Mettler Toledo International USD 248.39M 1.09M Sep/2025
Revvity USD 241.91M 9.6M Sep/2025
Solventum Corp USD 744M 28M Sep/2025
Stryker USD 2.14B 150M Dec/2025
Teleflex USD 281.76M 66.68M Sep/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Veeva Systems USD 128.19M 9.41M Sep/2025
Waters USD 214.23M 12.97M Sep/2025
Zimmer Biomet Holdings USD 811.4M 3.4M Sep/2025
Zoetis USD 579M 29M Sep/2025